
Biocon Biologics and Voluntis Join Hands for Global Collaboration on Digital Therapeutics for Insulins
Will Enable Access to Insulia®, an FDA-cleared and CE marked Digital Therapeutic, for Insulin-dependent Type 2 Diabetes Patients BENGALURU, India & PARIS & LONDON–(BUSINESS WIRE)–Regulatory […]
